Investing.com - Pacira (NASDAQ: PCRX) reported second quarter EPS of $0.89, $0.20 better than the analyst estimate of $0.69. Revenue for the quarter came in at $178M versus the consensus estimate of $173.52M.
Guidance
Pacira sees FY 2024 revenue of $680.00M-$705.00M versus the analyst consensus of $695.40M.
Pacira's stock price closed at $19.54. It is down -28.19% in the last 3 months and down -46.24% in the last 12 months.
Pacira saw 4 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Pacira's stock price’s past reactions to earnings here.
According to InvestingPro, Pacira's Financial Health score is "great performance".
Check out Pacira's recent earnings performance, and Pacira's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar